GlobalData on MSN
LEX Diagnostics secures FDA clearance for VELO PCR system
The system is intended for use in urgent care clinics, primary care settings, physician office laboratories, and pharmacies.
Expands range of applications for successful QIAcuity digital PCR platforms, now entering the clinical space across North America and the EU // Provides absolute quantitation, essential for precise ...
Over the past decade, PCR testing for infectious agents in the clinical laboratory has begun to replace other methods, such as culture. PCR is often now referred to as the gold standard in this field.
LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News: Eurofins (Paris:ERF) U.S. Clinical Diagnostics announced the launch date of its pooled PCR test to detect SARS-CoV-2 and significantly reduce the price ...
LOS ANGELES--(BUSINESS WIRE)--BiologyWorks™, Inc., a digital healthcare platform company, today announced that a substantive clinical trial of its handheld, reusable molecular test for COVID-19 ...
The FDA clearance represents a pivotal step in LEX Diagnostics’ strategy and underscores the company’s commitment to advancing point-of-care testing with accurate, timely, and clinically actionable ...
The multi‑year renewal strengthens ABL’s integrated platform, improving revenue visibility and supporting the Group’s ...
Karyotype analysis includes complete chromosome analysis of at least twenty metaphases with at least two cut karyotypes. The presence or absence of an acquired clonal chromosomal abnormality may aid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results